goralatide has been researched along with Sensitivity and Specificity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itoh, H; Katagiri, F; Kawasaki, K; Mimata, H; Sato, F; Sato, Y; Suzuki, Y; Takeyama, M | 1 |
| Haneda, M; Inomata, N; Kanasaki, K; Kato, Y; Kojima, R; Koya, D; Omata, M; Sho, R; Taniguchi, H | 1 |
| Azizi, M; Ezan, E; Grognet, JM; Ménard, J; Nicolet, L | 1 |
3 other study(ies) available for goralatide and Sensitivity and Specificity
| Article | Year |
|---|---|
Establishment and clinical application of a highly sensitive enzyme immunoassay for determination of N-acetyl-seryl-aspartyl-lysyl-proline.
Topics: Adult; Aged; Antibody Specificity; Anticoagulants; beta-Galactosidase; Biomarkers; Calibration; Case-Control Studies; Circadian Rhythm; Edetic Acid; Female; Heparin; Humans; Immune Sera; Immunoenzyme Techniques; Male; Middle Aged; Oligopeptides; Protein Stability; Reference Standards; Renal Insufficiency, Chronic; Sensitivity and Specificity | 2012 |
N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
Topics: Analysis of Variance; Animals; Anti-Glomerular Basement Membrane Disease; Biopsy, Needle; Blood Chemical Analysis; Blotting, Western; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Fibrosis; Immunohistochemistry; Injections, Subcutaneous; Kidney Function Tests; Male; Oligopeptides; Probability; Random Allocation; Rats; Rats, Inbred WKY; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Statistics, Nonparametric; Transforming Growth Factor beta; Urinalysis | 2006 |
High plasma level of N-acetyl-seryl-aspartyl-lysyl-proline: a new marker of chronic angiotensin-converting enzyme inhibition.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Biomarkers; Female; Humans; Male; Middle Aged; Oligopeptides; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System; Sensitivity and Specificity; Time Factors | 1997 |